Amy Liu

The impact of genetic risk on liver fibrosis in non‐alcoholic fatty liver disease as assessed by magnetic resonance elastography

D. Dhar, R. Loomba, V. Ajmera, 2021, Alimentary pharmacology & therapeutics.

Collagen Formation Assessed by N‐Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography

M. Karsdal, D. Brenner, C. Sirlin, 2019, Hepatology.

Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease

C. Sirlin, M. Valasek, R. Loomba, 2020, Hepatology.

Link between gut‐microbiome derived metabolite and shared gene‐effects with hepatic steatosis and fibrosis in NAFLD

Rohit Loomba, Chi-Hua Chen, Jonathan Hooker, 2018, Hepatology.

Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease

C. Sirlin, R. Loomba, J. Park, 2021, Alimentary pharmacology & therapeutics.

Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease

V. Wong, Dan-Qin Sun, Wen-Yue Liu, 2023, Alimentary pharmacology & therapeutics.

Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease

M. Valasek, R. Loomba, C. Behling, 2021, Therapeutic advances in gastroenterology.

Collagen Formation Assessed by N‐Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography

M. Karsdal, D. Brenner, C. Sirlin, 2019, Hepatology.